Skip to main content
Figure 3 | BMC Cardiovascular Disorders

Figure 3

From: Risk of valvular heart disease associated with use of fenfluramine

Figure 3

Estimated percent of incident cases with mild or greater AR arising during the exposure period (± 95% confidence intervals) versus duration of exposure to fenfluramine or dexfenfluramine. Some studies provided multiple point estimates based on different exposure times. The midpoint of the duration interval was used to plot these observations. Expected incident cases were calculated using the pooled estimate described in the text.

Back to article page